We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Will Wait for Additional Trial Data Before Approving Schering's Bonefos
FDA Will Wait for Additional Trial Data Before Approving Schering's Bonefos
May 11, 2005
The FDA will not consider approving Schering AG’s breast cancer drug Bonefos until after the results of a Phase III clinical trial are reported, the company said.